- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The CRISPR and CRISPR-Associated (Cas) Genes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global CRISPR and CRISPR-Associated (Cas) Genes market size is estimated to be worth US$ 1424.5 million in 2021 and is forecast to a readjusted size of USD 9195.8 million by 2028 with a CAGR of 30.5% during review period. Biotechnology Companies accounting for % of the CRISPR and CRISPR-Associated (Cas) Genes global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Genome Editing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of CRISPR and CRISPR-Associated (Cas) Genes include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, and Intellia therapeutics, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
CRISPR and CRISPR-Associated (Cas) Genes market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Market segment by Application, can be divided into
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Market segment by players, this report covers
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe CRISPR and CRISPR-Associated (Cas) Genes product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of CRISPR and CRISPR-Associated (Cas) Genes, with revenue, gross margin and global market share of CRISPR and CRISPR-Associated (Cas) Genes from 2019 to 2022.
Chapter 3, the CRISPR and CRISPR-Associated (Cas) Genes competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and CRISPR and CRISPR-Associated (Cas) Genes market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe CRISPR and CRISPR-Associated (Cas) Genes research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of CRISPR and CRISPR-Associated (Cas) Genes
1.2 Classification of CRISPR and CRISPR-Associated (Cas) Genes by Type
1.2.1 Overview: Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type in 2021
1.2.3 Genome Editing
1.2.4 Genetic engineering
1.2.5 gRNA Database/Gene Librar
1.2.6 CRISPR Plasmid
1.2.7 Human Stem Cells
1.2.8 Genetically Modified Organisms/Crops
1.2.9 Cell Line Engineering
1.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market by Application
1.3.1 Overview: Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size & Forecast
1.5 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast by Region
1.5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region, (2017-2022)
1.5.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospect (2017-2028)
1.5.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospect (2017-2028)
1.5.6 South America CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
1.6.2 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
1.6.3 CRISPR and CRISPR-Associated (Cas) Genes Trends Analysis
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.1.4 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Editas Medicine
2.2.1 Editas Medicine Details
2.2.2 Editas Medicine Major Business
2.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.2.4 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Editas Medicine Recent Developments and Future Plans
2.3 Caribou Biosciences
2.3.1 Caribou Biosciences Details
2.3.2 Caribou Biosciences Major Business
2.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.3.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Caribou Biosciences Recent Developments and Future Plans
2.4 CRISPR therapeutics
2.4.1 CRISPR therapeutics Details
2.4.2 CRISPR therapeutics Major Business
2.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.4.4 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 CRISPR therapeutics Recent Developments and Future Plans
2.5 Intellia therapeutics, Inc.
2.5.1 Intellia therapeutics, Inc. Details
2.5.2 Intellia therapeutics, Inc. Major Business
2.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.5.4 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Intellia therapeutics, Inc. Recent Developments and Future Plans
2.6 Cellectis
2.6.1 Cellectis Details
2.6.2 Cellectis Major Business
2.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.6.4 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Cellectis Recent Developments and Future Plans
2.7 Horizon Discovery Plc
2.7.1 Horizon Discovery Plc Details
2.7.2 Horizon Discovery Plc Major Business
2.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.7.4 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Horizon Discovery Plc Recent Developments and Future Plans
2.8 Sigma Aldrich
2.8.1 Sigma Aldrich Details
2.8.2 Sigma Aldrich Major Business
2.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.8.4 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Sigma Aldrich Recent Developments and Future Plans
2.9 Precision Biosciences
2.9.1 Precision Biosciences Details
2.9.2 Precision Biosciences Major Business
2.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.9.4 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Precision Biosciences Recent Developments and Future Plans
2.10 Genscript
2.10.1 Genscript Details
2.10.2 Genscript Major Business
2.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.10.4 Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Genscript Recent Developments and Future Plans
2.11 Sangamo Biosciences Inc.
2.11.1 Sangamo Biosciences Inc. Details
2.11.2 Sangamo Biosciences Inc. Major Business
2.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.11.4 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Sangamo Biosciences Inc. Recent Developments and Future Plans
2.12 Lonza Group Limited
2.12.1 Lonza Group Limited Details
2.12.2 Lonza Group Limited Major Business
2.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.12.4 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Lonza Group Limited Recent Developments and Future Plans
2.13 Integrated DNA Technologies
2.13.1 Integrated DNA Technologies Details
2.13.2 Integrated DNA Technologies Major Business
2.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.13.4 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Integrated DNA Technologies Recent Developments and Future Plans
2.14 New England Biolabs
2.14.1 New England Biolabs Details
2.14.2 New England Biolabs Major Business
2.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.14.4 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 New England Biolabs Recent Developments and Future Plans
2.15 Origene Technologies
2.15.1 Origene Technologies Details
2.15.2 Origene Technologies Major Business
2.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.15.4 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Origene Technologies Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 CRISPR and CRISPR-Associated (Cas) Genes Players Market Share in 2021
3.2.2 Top 10 CRISPR and CRISPR-Associated (Cas) Genes Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 CRISPR and CRISPR-Associated (Cas) Genes Players Head Office, Products and Services Provided
3.4 CRISPR and CRISPR-Associated (Cas) Genes Mergers & Acquisitions
3.5 CRISPR and CRISPR-Associated (Cas) Genes New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue and Market Share by Type (2017-2022)
4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2017-2022)
5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2017-2028)
6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2017-2028)
6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
6.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2017-2028)
6.3.2 United States CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
6.3.3 Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
6.3.4 Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2017-2028)
7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2017-2028)
7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
7.3.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2017-2028)
7.3.2 Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
7.3.3 France CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
7.3.4 United Kingdom CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
7.3.5 Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
7.3.6 Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2017-2028)
8.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2017-2028)
8.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region
8.3.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2017-2028)
8.3.2 China CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
8.3.3 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
8.3.4 South Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
8.3.5 India CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
8.3.7 Australia CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2017-2028)
9.2 South America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2017-2028)
9.3 South America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
9.3.1 South America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2017-2028)
9.3.2 Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
9.3.3 Argentina CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2017-2028)
10.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2017-2028)
10.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
10.3.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2017-2028)
10.3.2 Turkey CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
10.3.4 UAE CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market CRISPR and CRISPR-Associated (Cas) Genes Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million) by Region (2017-2022)
Table 5. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2023-2028)
Table 6. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Scientific Major Business
Table 8. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 9. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Editas Medicine Corporate Information, Head Office, and Major Competitors
Table 11. Editas Medicine Major Business
Table 12. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 13. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Caribou Biosciences Corporate Information, Head Office, and Major Competitors
Table 15. Caribou Biosciences Major Business
Table 16. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 17. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. CRISPR therapeutics Corporate Information, Head Office, and Major Competitors
Table 19. CRISPR therapeutics Major Business
Table 20. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 21. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Intellia therapeutics, Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Intellia therapeutics, Inc. Major Business
Table 24. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 25. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Cellectis Corporate Information, Head Office, and Major Competitors
Table 27. Cellectis Major Business
Table 28. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 29. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Horizon Discovery Plc Corporate Information, Head Office, and Major Competitors
Table 31. Horizon Discovery Plc Major Business
Table 32. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 33. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Sigma Aldrich Corporate Information, Head Office, and Major Competitors
Table 35. Sigma Aldrich Major Business
Table 36. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 37. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Precision Biosciences Corporate Information, Head Office, and Major Competitors
Table 39. Precision Biosciences Major Business
Table 40. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 41. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Genscript Corporate Information, Head Office, and Major Competitors
Table 43. Genscript Major Business
Table 44. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 45. Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Sangamo Biosciences Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Sangamo Biosciences Inc. Major Business
Table 48. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 49. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Lonza Group Limited Corporate Information, Head Office, and Major Competitors
Table 51. Lonza Group Limited Major Business
Table 52. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 53. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Integrated DNA Technologies Corporate Information, Head Office, and Major Competitors
Table 55. Integrated DNA Technologies Major Business
Table 56. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 57. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. New England Biolabs Corporate Information, Head Office, and Major Competitors
Table 59. New England Biolabs Major Business
Table 60. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 61. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Origene Technologies Corporate Information, Head Office, and Major Competitors
Table 63. Origene Technologies Major Business
Table 64. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 65. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 67. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 68. Breakdown of CRISPR and CRISPR-Associated (Cas) Genes by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. CRISPR and CRISPR-Associated (Cas) Genes Players Head Office, Products and Services Provided
Table 70. CRISPR and CRISPR-Associated (Cas) Genes Mergers & Acquisitions in the Past Five Years
Table 71. CRISPR and CRISPR-Associated (Cas) Genes New Entrants and Expansion Plans
Table 72. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million) by Type (2017-2022)
Table 73. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Type (2017-2022)
Table 74. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Type (2023-2028)
Table 75. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2017-2022)
Table 76. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Application (2023-2028)
Table 77. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2017-2022) & (USD Million)
Table 78. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2023-2028) & (USD Million)
Table 79. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2017-2022) & (USD Million)
Table 80. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2023-2028) & (USD Million)
Table 81. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2017-2022) & (USD Million)
Table 82. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2023-2028) & (USD Million)
Table 83. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2017-2022) & (USD Million)
Table 84. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2023-2028) & (USD Million)
Table 85. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2017-2022) & (USD Million)
Table 86. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2023-2028) & (USD Million)
Table 87. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2017-2022) & (USD Million)
Table 88. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2023-2028) & (USD Million)
Table 89. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2017-2022) & (USD Million)
Table 90. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2023-2028) & (USD Million)
Table 91. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2017-2022) & (USD Million)
Table 92. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2023-2028) & (USD Million)
Table 93. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2017-2022) & (USD Million)
Table 94. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2023-2028) & (USD Million)
Table 95. South America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2017-2022) & (USD Million)
Table 96. South America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2023-2028) & (USD Million)
Table 97. South America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2017-2022) & (USD Million)
Table 98. South America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2023-2028) & (USD Million)
Table 99. South America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2017-2022) & (USD Million)
Table 100. South America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2023-2028) & (USD Million)
Table 101. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2017-2022) & (USD Million)
Table 102. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2023-2028) & (USD Million)
Table 103. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2017-2022) & (USD Million)
Table 104. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2023-2028) & (USD Million)
Table 105. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2017-2022) & (USD Million)
Table 106. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Picture
Figure 2. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type in 2021
Figure 3. Genome Editing
Figure 4. Genetic engineering
Figure 5. gRNA Database/Gene Librar
Figure 6. CRISPR Plasmid
Figure 7. Human Stem Cells
Figure 8. Genetically Modified Organisms/Crops
Figure 9. Cell Line Engineering
Figure 10. CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application in 2021
Figure 11. Biotechnology Companies Picture
Figure 12. Pharmaceutical Companies Picture
Figure 13. Academic Institutes Picture
Figure 14. Research and Development Institutes Picture
Figure 15. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 16. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2017-2028)
Figure 18. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region in 2021
Figure 19. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. South America CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
Figure 25. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
Figure 26. CRISPR and CRISPR-Associated (Cas) Genes Market Trends
Figure 27. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 28. Editas Medicine Recent Developments and Future Plans
Figure 29. Caribou Biosciences Recent Developments and Future Plans
Figure 30. CRISPR therapeutics Recent Developments and Future Plans
Figure 31. Intellia therapeutics, Inc. Recent Developments and Future Plans
Figure 32. Cellectis Recent Developments and Future Plans
Figure 33. Horizon Discovery Plc Recent Developments and Future Plans
Figure 34. Sigma Aldrich Recent Developments and Future Plans
Figure 35. Precision Biosciences Recent Developments and Future Plans
Figure 36. Genscript Recent Developments and Future Plans
Figure 37. Sangamo Biosciences Inc. Recent Developments and Future Plans
Figure 38. Lonza Group Limited Recent Developments and Future Plans
Figure 39. Integrated DNA Technologies Recent Developments and Future Plans
Figure 40. New England Biolabs Recent Developments and Future Plans
Figure 41. Origene Technologies Recent Developments and Future Plans
Figure 42. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Players in 2021
Figure 43. CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 44. Global Top 3 Players CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share in 2021
Figure 45. Global Top 10 Players CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share in 2021
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 47. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Type in 2021
Figure 48. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Type (2023-2028)
Figure 49. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Application in 2021
Figure 50. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Application (2023-2028)
Figure 51. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2017-2028)
Figure 52. North America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2017-2028)
Figure 53. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Country (2017-2028)
Figure 54. United States CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Canada CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Mexico CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2017-2028)
Figure 58. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2017-2028)
Figure 59. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Country (2017-2028)
Figure 60. Germany CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. France CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. United Kingdom CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Russia CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Italy CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2017-2028)
Figure 66. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2017-2028)
Figure 67. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2017-2028)
Figure 68. China CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South Korea CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. India CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Australia CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2017-2028)
Figure 75. South America CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2017-2028)
Figure 76. South America CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Country (2017-2028)
Figure 77. Brazil CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Argentina CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Country (2017-2028)
Figure 82. Turkey CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Saudi Arabia CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. UAE CRISPR and CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
